Interactions between tafenoquine and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum

Karen Kemirembe, Mynthia Cabrera, Liwang Cui

Research output: Contribution to journalArticle

5 Scopus citations


The 8-aminoquinoline tafenoquine (TFQ), a primaquine derivative, is currently in late-stage clinical development for the radical cure of P. vivax. Here drug interactions between TFQ and chloroquine and six artemisinin-combination therapy (ACT) partner drugs in P. falciparum asexual stages and gametocytes were investigated. TFQ was mostly synergistic with the ACT-partner drugs in asexual parasites regardless of genetic backgrounds. However, at fixed ratios of 1:3, 1:1 and 3:1, TFQ only interacted synergistically with naphthoquine, pyronaridine and piperaquine in gametocytes. This study indicated that TFQ and ACT-partner drugs will likely have increased potency against asexual stages of the malaria parasites, whereas some drugs may interfere with each other against the P. falciparum gametocytes.

Original languageEnglish (US)
Pages (from-to)131-137
Number of pages7
JournalInternational Journal for Parasitology: Drugs and Drug Resistance
Issue number2
StatePublished - Aug 1 2017


All Science Journal Classification (ASJC) codes

  • Parasitology
  • Infectious Diseases
  • Pharmacology (medical)

Cite this